Plasma levels of soluble glycoprotein 130 in acute myocardial infarction

Journal of Cardiology

Volumn 50, Issue 2, 2007, Pages 101-109

  Ichiki, Tomoko ^a   Jougasaki, Michihisa ^a   Setoguchi, Manabu ^a   Shimokawahara, Hiroto ^a   Nakashima, Hitoshi ^a   Matsuoka, Tatsuru ^a   Sonoda, Masahiro ^a   Nakamura, Kazuhiko ^a   Minagoe, Shinichi ^a   Tei, Chuwa ^b  

^a NATIONAL HOSPITAL ORGANIZATION KAGOSHIMA MEDICAL CENTER   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Blood cells; Cytokines; Myocardial infarction; Pathophysiology

Indexed keywords

C REACTIVE PROTEIN; GLYCOPROTEIN; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR;

AGED; ARTICLE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART INFARCTION; HUMAN; LEUKOCYTE COUNT; MALE; METABOLISM; PATHOPHYSIOLOGY;

AGED; C-REACTIVE PROTEIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPROTEINS; HUMANS; INTERLEUKIN-6; LEUKOCYTE COUNT; MALE; MYOCARDIAL INFARCTION; RECEPTORS, INTERLEUKIN-6;

EID: 34848894237     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Heinrich PC, Behrmann I, Miiller-Newen G, Schaper F, Graeve L: Interleukin-6-type cytokine signalling through the gpl30/Jak/STAT pathway. Biochem J 1998;334:297-314 (Pubitemid 28448572)
2. Saito M, Yoshida K, Hibi M, Taga T, Kishimoto T: Molecular cloning of murine IL-6 receptor-associated signal transducer, gp 130, and its regulated expression in vivo. J Immunol 1992;148:4066-4071
3. Kishimoto T, Taga T, Akira S: Cytokine signal transduction. Cell 1994;76:253-262 (Pubitemid 24046688)
4. Kishimoto T, Akira S, Narazaki M, Taga T: Interleukin-6 family of cytokines and gpl30. Blood 1995;86:1243-1254
5. Yoshida K, Taga T, Saito M, Suematsu S, Kumanogoh A, Tanaka T, Fujiwara H, Hirata M, Yamagami T, Nakahata T, Hirabayashi T, Yoneda Y, Tanaka K, Wang WZ, Mori C, Shiota K, Yoshida N, Kishimoto T: Targeted disruption of gpl30, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc Natl Acad Sci U S A 1996;93:407-411 (Pubitemid 26041485)
6. Hirota H, Chen J, Betz UA, Rajewsky K, Gu Y, Ross J Jr, Miiller W, Chien KR: Loss of a gpl30 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechamical stress. Cell 1999;97:189-198 (Pubitemid 29194270)
7. Hirota H, Yoshida K, Kishimoto T, Taga T: Continuous activation of gpl30, a signal-transducing receptor component for interleukin-6-related cytokines, causes myocardial hypertrophy in mice. Proc Natl Acad Sci U S A 1995;92:4862-4866
8. Honda M, Yamamoto S, Cheng M, Yasukawa K, Suzuki H, Saito T, Osugi Y, Tokunaga T, Kishimoto T: Human soluble IL-6 receptor: Its detection and enhanced release by HIV infection. J Immunol 1992;148:2175-2180
9. Taga T, Hibi M, Hirata Y, Yamasaki K, Yasukawa K, Matsuda T, Hirano T, Kishimoto T: Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp 130. Cell 1989;58:573-581 (Pubitemid 19203542)
10. Zhang JG, Zhang Y, Owczarek CM, Ward LD, Moritz RL, Simpson RJ, Yasukawa K, Nicola NA: Identification and characterization of two distinct truncated forms of gp 130 and a soluble form of leukemia inhibitory factor receptor α-chain in normal human urine and plasma. J Biol Chem 1998;273:10798-10805 (Pubitemid 28227698)
11. Ward LD, Howlett GJ, Discolo G, Yasukawa K, Hammacher A, Moritz RL, Simpson RJ: High affinity interleukin-6 receptor is a hexametric complex consisting of two molecules each of interleukin-6, interleukin-6 receptor, and gpl30. J Biol Chem 1994;269:23286-23289 (Pubitemid 24283319)
12. Müller-Newen G, Kuster A, Hemmann U, Keul R, Horsten U, Martens A, Graeve L, Wijdenes J, Heinrich PC: Soluble IL-6 receptor potentiates the antagonistic activity of soluble 8P130 on IL-6 responses. J Immunol 1998;161:6347-6355 (Pubitemid 28536011)
13. Narazaki M, Yasukawa K, Saito T, Ohsugi Y, Fukui H, Koishihara Y, Yancopoulos GD, Taga T, Kishimoto T: Soluble forms of the interleukin-6 signal-transducing receptor component gp 130 in human serum possessing a potential to inhibit signals through membrane-anchored gp 130. Blood 1993;82:1120-1126 (Pubitemid 23253984)
14. Ancey C, Kuster A, Haan S, Herrmann A, Heinrich PC, Müller-Newen G: A fusion protein of the gpl30 and interukin-6Rα ligand-binding domains acts as a potent interleukin-6 inhibitor. J Biol Chem 2003;278:16968-16972 (Pubitemid 36799571)
15. Jostock T, Mullberg J, Ozbek S, Atreya R, Blinn G, Voltz N, Fischer M, Neurath MF, Rose-John S: Soluble gpl30 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur J Biochem 2001;268:160-167 (Pubitemid 32052260)
16. Petretta M, Condorelli GL, Spinelli L, Scopacasa F, De Caterina M, Leosco D, Vicario ML, Bonaduce D: Circulating levels of cytokines and their site of production in Patients with mild to severe chronic heart failure. Am Heart J 2000;140:E28
17. Hirota H, Izumi M, Hamaguchi T, Sugiyama S, Murakami E, Kunisada K, Fujio Y, Oshima Y, Nakaoka Y, Yamauchi-Takihara K: Circulating interleukin-6 family cytokines and their receptors in patients with congestive heart failure. Heart Vessels 2004;19:237-241 (Pubitemid 39335083)
18. Corbi P, Rahmati M, Delwail A, Potreau D, Menu P, Wijdenes J, Lecron JC: Circulating soluble gpl30, soluble IL-6R, and IL-6 in patients undergoing cardiac surgery, with or without extracorporeal circulation. Eur J Cardiothorac Surg 2000;18:98-103 (Pubitemid 30408634)
19. Tashir H, Shimokawa H, Yamamoto K, Nagano M, Momohara M, Muramatu K, Takeshita A: Monocyte-related cytokines in acute myocardial infarction. Am Heart J 1995;130:446-452
20. Miyao Y, Yasue H, Ogawa H, Misumi I, Masuda T, Sakamoto T, Morita E: Elevated plasma interleukin-6 levels in patients with acute myocardial infarction. Am Heart J 1993:126:1299-1304 (Pubitemid 24000023)
21. Neumann FJ, Ott I, Gawaz M, Richardt G, Holzapfel H. Jochum M, Schomig A: Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 1995;92:748-755
22. Ikeda U, Ohkawa F, Seino Y, Yamamoto K. Hidaka Y, Kasahara T, Kawai T, Shimada K: Serum interleukin-6 evels become elevated in acute myocardial infarction. J Mol Cell Cardiol 1992;24:579-584
23. Aoyama T, Takimoto Y, Pennica D, Inoue R. Shinoda E, Hattori R, Yui Y, Sasayama S: Augmented expression of cardiotrophin-l and its receptor component, gpl30, in both left and right ventricles after myocardial infarction in the rat. J Mol Cell Cardiol 2000;32:1821-1830
24. Tei C: New non-invasive index for combined systolic and diastolic ventricular function. J Cardiol 1995;26:135-136
25. Morita E, Yasue H, Yoshimura M, Ogawa H, Jougasaki M, Matsumura T, Mukoyama M, Nakao K: Increased plasma levels of brain natriuretic peptide in patients with acute myocardidal infarction. Circulation 1993;88:82-91 (Pubitemid 23195436)
26. Memoli B, Grandaliano G, Soccio M, Postiglione L, Guida B, Bisesti V, Esposito P, Procino A, Marrone D, Michael A, Andreucci M, Schena FP, Pertosa G: In vivo modulation of soluble "antagonistic" IL-6 receptor synthesis and release in ERSD. J Am Soc Nephrol 2005;16:1099-1107 (Pubitemid 41710321)
27. Althoff K, Mullberg J, Aasland D, Volts N, Kallen KJ, Grdtzinger J, Rose-John S: Recognition sequences and structural elements contribute to shedding susceptibility of membrane proteins. Biochem J 2001;353:663-672 (Pubitemid 32158335)
28. Vermes C, Jacobs JJ, Zhang J, Firneisz G, Roebuck KA, Giant TT: Shedding of the interleukin-6 (IL-6) receptor (gp80) determines the ability of IL-6 to induce gpl30 phosphorylation in human osteoblasts. J Biol Chem 2002;277:16879-16887 (Pubitemid 34967713)
29. Acalovschi D, Wiest T, Hartmann M, Farahmi M, Mansmann U, Auffarth GU, Grau AJ, Green FR, Grond-Ginsbach C, Schwaninger M: Multiple levels of regulation of the interleukin-6 system in stroke. Stroke 2003;34:1864-1869 (Pubitemid 36944770)
30. Mossetti G, Rendina D, De Filippo G, Viceconti R, Di Domenico G, Cioffi M, Postiglione L, Nunziata V: Interleukin-6 and osteoprotegerin systems in Paget's disease of bone: Relationship to risedronate treatment. Bone 2005;36:549-554 (Pubitemid 40403853)
31. Beeton CA, Chatfield D, Brooks RA, Rushton N: Circulating levels of interleukin-6 and its soluble receptor in patients with head injury and fracture. J Bone Joint Surg Br 2004;86:912-917 (Pubitemid 39173480)
32. Gustot T, Lemmers A, Louis E, Nicaise C, Quertinmont E, Belaiche J, Roland S, Van Gossum A, Deviere J, Franchimont D: Profile of soluble cytokine receptors in Crohn's disease. Gut 2005;54:488-495 (Pubitemid 40395500)
33. Kovacs E: Investigation of interleukin-6 (IL-6), soluble IL-6 receptor (sIL-6R) and soluble gpl30 (sgpl30) in sera of cancer patients. Biomed Pharmacother 2001;55:391-396 (Pubitemid 32900539)
34. Tjerenlund A, Barqasho B, Nowak P, Kinloch S, Thorborn D, Perrin L, Sonnerborg A, Walther-Jallow L, Andersson J: Early induction of leukemia inhibitor factor (LIF) in acute HIV-1 infection. AIDS 2006;20:11-19 (Pubitemid 41818109)
35. 2/BSF2/IL-6 is the monocyte-derived HSF that regulates receptor-specific acute phase gene regulation in hepatocytes. Ann N Y Acad Sci 1989;557:46-58
36. Moshage HJ, Roelofs HM, Van Pelt JF, Hazenberg BP, Van Leeuwen MA, Limberg PC, Aarden LA, Yap SH: The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes. Biochem Biophys Res Commun 1988;155:112-117